Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z


Division of Vector-Borne Infectious Diseases Dengue: Clinical Manifestations and Epidemiology

 
slide 9 of 12
 Back Menu Table of contents Next
 

Hypothesis on Pathogenesis of DHF (Part 3)

  • Antibody-dependent enhancement is the process in which certain strains of dengue virus, complexed with non-neutralizing antibodies, can enter a greater proportion of cells of the mononuclear lineage, thus increasing virus production
Antibody-dependent enhancement is the process in which certain strains of dengue virus, complexed with these non-neutralizing antibodies, can enter a greater proportion of the mononuclear cells where the virus replicates unchecked, thus increasing virus production and producing a massive infection.

Esta página en Español

Back | Menu | Next |

CDC Home | Search | Health Topics A-Z |

This page last reviewed February 13, 2002

Division of Vector-Borne Infectious Diseases |
National Center for Infectious Diseases |
Centers for Disease Control and Prevention |
P.O. Box 2087
Fort Collins, Colorado 80522

CDC Privacy Policy | Accessibility |